Literature DB >> 32271433

Down-regulation of long non-coding RNA DUXAP8 suppresses proliferation, metastasis and EMT by modulating miR-498 through TRIM44-mediated AKT/mTOR pathway in non-small-cell lung cancer.

X Ji1, R Tao, L-Y Sun, X-L Xu, W Ling.   

Abstract

OBJECTIVE: The long non-coding RNA double homeobox A pseudogene 8 (DUXAP8) was reported to be involved in the initiation and development of multiple cancers. However, the detailed biological role of DUXAP8 in non-small-cell lung cancer (NSCLC) remains unclear. Herein, we aimed to explore the biological function and molecular mechanism of DUXAP8 in NSCLC. PATIENTS AND METHODS: The levels of DUXAP8, microRNA-498 (miR-498) and tripartite motif-44 (TRIM44) were detected by Quantitative Real-time polymerase chain reaction (qRT-PCR). The cell proliferation, migration and invasion were detected by 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and transwell assays. Protein expression levels were detected by Western blot. The target relationships among DUXAP8, miR-498 and TRIM44 were predicted by starBase2.0 and confirmed using luciferase reporter and RNA pull-down assays. To detect the role of DUXAP8 in vivo, tumor xenografts were created.
RESULTS: DUXAP8 and TRIM44 were upregulated in NSCLC tissues and cell lines, while miR-498 was downregulated. Functionally, knockdown of DUXAP8 could repress proliferation, migration, invasion, Epithelial-Mesenchymal Transition (EMT) and phosphorylation of AKT/mTOR in NSCLC cells. This inhibition could be restored by inhibiting miR-498 or overexpressing TRIM44. Furthermore, we also observed a positive correlation between DUXAP8 and TRIM44 expression, while the expressions of miR-498 and DUXAP8, as well as miR-498 and TRIM44, were negatively correlated in NSCLC tissues. Importantly, DUXAP8 could regulate the expression of TRIM44 via miR-498. Moreover, knockdown of DUXAP8 notably decreased the xenograft tumor volume, weight and number of metastatic nodules in vivo.
CONCLUSIONS: Our results identified that LncRNA DUXAP8 could regulate cell proliferation, metastasis and EMT in NSCLC cells by inhibiting miR-498 through the activation of TRIM44-mediated AKT/mTOR pathway.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32271433     DOI: 10.26355/eurrev_202003_20682

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  13 in total

Review 1.  Functions of lncRNA DUXAP8 in non-small cell lung cancer.

Authors:  Cui Wu; Wu Song; Zhongnan Wang; Bingmei Wang
Journal:  Mol Biol Rep       Date:  2022-01-15       Impact factor: 2.316

Review 2.  Long Noncoding RNAs and Circular RNAs in the Metabolic Reprogramming of Lung Cancer: Functions, Mechanisms, and Clinical Potential.

Authors:  Yuhao Zhou; Yuan Zhan; Weiling Jiang; Huiguo Liu; Shuang Wei
Journal:  Oxid Med Cell Longev       Date:  2022-06-15       Impact factor: 7.310

3.  CircFBXW8 Acts an Oncogenic Role in the Malignant Progression of Non-small Cell Lung Carcinoma by miR-370-3p-Dependent Regulation of TRIM44.

Authors:  Xia Wang; Jian Lv; Bin He; Deqi Zhou
Journal:  Biochem Genet       Date:  2022-01-06       Impact factor: 2.220

4.  Knockdown of circRAD23B Exerts Antitumor Response in Colorectal Cancer via the Regulation of miR-1205/TRIM44 axis.

Authors:  Bingbing Han; Xiaohong Wang; Xia Yin
Journal:  Dig Dis Sci       Date:  2021-02-25       Impact factor: 3.199

5.  LncRNA HOTAIRM1 knockdown inhibits cell glycolysis metabolism and tumor progression by miR-498/ABCE1 axis in non-small cell lung cancer.

Authors:  Dongping Chen; Yashan Li; Yukang Wang; Jinlian Xu
Journal:  Genes Genomics       Date:  2021-02-03       Impact factor: 1.839

6.  Long non‑coding RNA PITPNA‑AS1 silencing suppresses proliferation, metastasis and epithelial‑mesenchymal transition in non‑small cell lung cancer cells by targeting microRNA‑32‑5p.

Authors:  Gang Chen; Zhifeng Zheng; Junsheng Li; Peigang Zhang; Zhenjun Wang; Shiping Guo; Jun Ma; Jian Shen; Huixin Li
Journal:  Mol Med Rep       Date:  2021-01-26       Impact factor: 2.952

7.  Identification of long non-coding RNA signatures for squamous cell carcinomas and adenocarcinomas.

Authors:  Suyan Tian; Mingbo Tang; Jialin Li; Chi Wang; Wei Liu
Journal:  Aging (Albany NY)       Date:  2020-12-09       Impact factor: 5.682

8.  Circ_0000658 knockdown inhibits epithelial-mesenchymal transition in bladder cancer via miR-498-induced HMGA2 downregulation.

Authors:  Feng Qiu; Qiuchen Liu; Yanfu Xia; Hengxi Jin; Yuxin Lin; Xiaojun Zhao
Journal:  J Exp Clin Cancer Res       Date:  2022-01-14

9.  Targeting the lncRNA DUXAP8/miR-29a/PIK3CA Network Restores Doxorubicin Chemosensitivity via PI3K-AKT-mTOR Signaling and Synergizes With Inotuzumab Ozogamicin in Chemotherapy-Resistant B-Cell Acute Lymphoblastic Leukemia.

Authors:  Li Zhang; Shixia Zhou; Tiejun Zhou; Xiaoming Li; Junling Tang
Journal:  Front Oncol       Date:  2022-03-02       Impact factor: 6.244

Review 10.  The World of Pseudogenes: New Diagnostic and Therapeutic Targets in Cancers or Still Mystery Molecules?

Authors:  Maciej Stasiak; Tomasz Kolenda; Joanna Kozłowska-Masłoń; Joanna Sobocińska; Paulina Poter; Kacper Guglas; Anna Paszkowska; Renata Bliźniak; Anna Teresiak; Urszula Kazimierczak; Katarzyna Lamperska
Journal:  Life (Basel)       Date:  2021-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.